Format

Send to:

Choose Destination
See comment in PubMed Commons below
Transplantation. 2006 Jul 27;82(2 Suppl):S4-8.

Benefits of cytomegalovirus prophylaxis in solid organ transplantation.

Author information

  • 1Department of Surgery , Indiana University School of Medicine, Indianapolis, IN 46202, USAmpescov@iupui.edu.

Abstract

The benefits of cytomegalovirus (CMV) prophylaxis in preventing the direct effects of CMV infection and disease are well established; however, the impact of exposure to antiviral agents on preventing the indirect effects of CMV infection are poorly defined. This article reviews the results of current studies demonstrating the benefits of CMV prophylaxis in reducing the risks of indirect effects of CMV infection: acute and chronic allograft rejection, graft failure, patient mortality, cardiac complications and atherosclerosis, and posttransplant lymphoproliferative disorder, in solid organ transplant recipients.

PMID:
16858270
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk